Search research articles
Contact Us
Filters
Showing results (21-30 of 24) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 24 results.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
William R Lumry, Timothy Craig, Bruce Zuraw, et al.
The Journal of Allergy and Clinical Immunology
|
November 18, 2000
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma
J E Fish, J P Karpel, T J Craig, et al.
The Journal of Allergy and Clinical Immunology
|
October 25, 2020
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
Bruce Zuraw, William R Lumry, Douglas T Johnston, et al.
The New England Journal of Medicine
|
March 23, 2017
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
Hilary Longhurst, Marco Cicardi, Timothy Craig, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 24) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 24 results.
The Journal of Allergy and Clinical Immunology. in Practice
|
February 3, 2018
Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema
William R Lumry, Timothy Craig, Bruce Zuraw, et al.
The Journal of Allergy and Clinical Immunology
|
November 18, 2000
Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma
J E Fish, J P Karpel, T J Craig, et al.
The Journal of Allergy and Clinical Immunology
|
October 25, 2020
Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial
Bruce Zuraw, William R Lumry, Douglas T Johnston, et al.
The New England Journal of Medicine
|
March 23, 2017
Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor
Hilary Longhurst, Marco Cicardi, Timothy Craig, et al.
Page
of 3